Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel S Key

Showing results (21-30 of 255) with videos related to

Pageof 26
Sort By:
Seminars in Interventional Radiology|March 2, 2013
Medical management of venous thromboembolism: what the interventional radiologist needs to knowRaj S Kasthuri, Nigel S Key
Blood|April 16, 2016
Genetic basis of ethnic disparities in VTE riskNigel S Key, Alex P Reiner
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 24, 2015
Microparticle analysis in disorders of hemostasis and thrombosisMicah J Mooberry, Nigel S Key
Archives of Pathology & Laboratory Medicine|November 8, 2002
Hyperhomocyst(e)inemia and ThrombophiliaNigel S Key, Ronald C McGlennen
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 4, 2011
The microbubble or the microparticle?Martha Sue Carraway, Nigel S Key
Hematology. American Society of Hematology. Education Program|November 21, 2007
Hypercoagulability in sickle cell disease: new approaches to an old problemKenneth I Ataga, Nigel S Key
Seminars in Thrombosis and Hemostasis|July 28, 2025
Red Blood Cell Extracellular Vesicles as Key Players in ThromboinflammationDenis F Noubouossie, Nigel S Key
Hematology. American Society of Hematology. Education Program|January 18, 2011
Sickle-cell trait: novel clinical significanceNigel S Key, Vimal K Derebail
British Journal of Haematology|May 3, 2016
Microparticles in sickle cell anaemia: promise and pitfallsRobert P Hebbel, Nigel S Key
Seminars in Hematology|February 12, 2004
Views on methods for monitoring recombinant factor VIIa in inhibitor patientsNigel S Key, Gary L Nelsestuen
Pageof 26

Showing results (21-30 of 255) with videos related to

Sort By:
Pageof 26
Seminars in Interventional Radiology|March 2, 2013
Medical management of venous thromboembolism: what the interventional radiologist needs to knowRaj S Kasthuri, Nigel S Key
Blood|April 16, 2016
Genetic basis of ethnic disparities in VTE riskNigel S Key, Alex P Reiner
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 24, 2015
Microparticle analysis in disorders of hemostasis and thrombosisMicah J Mooberry, Nigel S Key
Archives of Pathology & Laboratory Medicine|November 8, 2002
Hyperhomocyst(e)inemia and ThrombophiliaNigel S Key, Ronald C McGlennen
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 4, 2011
The microbubble or the microparticle?Martha Sue Carraway, Nigel S Key
Hematology. American Society of Hematology. Education Program|November 21, 2007
Hypercoagulability in sickle cell disease: new approaches to an old problemKenneth I Ataga, Nigel S Key
Seminars in Thrombosis and Hemostasis|July 28, 2025
Red Blood Cell Extracellular Vesicles as Key Players in ThromboinflammationDenis F Noubouossie, Nigel S Key
Hematology. American Society of Hematology. Education Program|January 18, 2011
Sickle-cell trait: novel clinical significanceNigel S Key, Vimal K Derebail
British Journal of Haematology|May 3, 2016
Microparticles in sickle cell anaemia: promise and pitfallsRobert P Hebbel, Nigel S Key
Seminars in Hematology|February 12, 2004
Views on methods for monitoring recombinant factor VIIa in inhibitor patientsNigel S Key, Gary L Nelsestuen
Pageof 26